The cardioprotective effects of fish oil during pressure overload are blocked by high fat intake: Role of cardiac phospholipid remodeling

Hypertension

Volumn 54, Issue 3, 2009, Pages 605-611

  Shah, Keyur B ^a   Duda, Monika K ^a,b   O'Shea, Karen M ^c   Sparagna, Genevieve C ^d   Chess, David J ^a   Khairallah, Ramzi J ^a   Robillard Frayne, Isabelle ^e   Xu, Wenhong ^a   Murphy, Robert C ^e   Rosiers, Christine Des ^f   Stanley, William C ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e MONTREAL HEART INSTITUTE   (Canada)

^f UNIVERSITY OF COLORADO   (United States)

Author keywords

Cardiac hypertrophy; Cardiolipin; Heart failure; Omega 3 fatty acids; Phospolipids

Indexed keywords

ARACHIDONIC ACID; ATRIAL NATRIURETIC FACTOR; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; MYOSIN HEAVY CHAIN BETA; OMEGA 3 FATTY ACID; PHOSPHOLIPID; TETRALINOLOYL CARDIOLIPIN; THROMBOXANE B2; UNCLASSIFIED DRUG; BMYO PROTEIN, RAT; CARDIOLIPIN; CARDIOTONIC AGENT; MYOSIN HEAVY CHAIN; TETRALINOLEOYLCARDIOLIPIN;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFICACY; ENERGY METABOLISM; FEEDING; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART PROTECTION; HEART VENTRICLE OVERLOAD; HEART VENTRICLE PRESSURE; LIPID DIET; MALE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; URINE; VASOCONSTRICTION; ANIMAL; BLOOD PRESSURE; BODY WEIGHT; CHEMISTRY; DRUG EFFECT; ECHOCARDIOGRAPHY; FAT INTAKE; LIGATION; METABOLISM; ORGAN SIZE; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALS; AORTA, ABDOMINAL; ARACHIDONIC ACID; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; BODY WEIGHT; CARDIOLIPINS; CARDIOTONIC AGENTS; CONSTRICTION; DIETARY FATS; DOCOSAHEXAENOIC ACIDS; ECHOCARDIOGRAPHY; EICOSAPENTAENOIC ACID; FISH OILS; HYPERTROPHY, LEFT VENTRICULAR; LINOLEIC ACID; MALE; MYOCARDIUM; MYOSIN HEAVY CHAINS; ORGAN SIZE; PHOSPHOLIPIDS; RATS; RATS, WISTAR; THROMBOXANE B2;

EID: 70349231115     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.135806     Document Type: Article

References (29)

1. Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM, Hunter D, Manson JE. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA. 2002;287:1815-1821.
2. Mozaffarian D, Lemaitre RN, Kuller LH, Burke GL, Tracy RP, Siscovick DS. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation. 2003;107: 1372-1377.
3. Yamagishi K, Iso H, Date C, Fukui M, Wakai K, Kikuchi S, Inaba Y, Tanabe N, Tamakoshi A. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the J Am Coll Cardiol (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J Am Coll Cardiol. 2008;52:988-996.
4. Sinclair HM. Deficiency of essential fatty acids and atherosclerosis, etcetera. Lancet. 1956;270:381-383.
5. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354:447-455.
6. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2:757-761.
7. Mozaffarian D, Bryson CL, Lemaitre RN, Burke GL, Siscovick DS. Fish intake and risk of incident heart failure. J Am Coll Cardiol. 2005;45: 2015-2021. (Pubitemid 40814125)
8. Gissi-Hf I. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:1223-1230.
9. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83:1505S-1519S.
10. Pepe S, McLennan PL. Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation. 2002;105:2303-2308.
11. Duda MK, O'Shea KM, Lei B, Barrows BR, Azimzadeh AM, McElfresh TE, Hoit BD, Kop WJ, Stanley WC. Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc Res. 2007;76:303-310.
12. Duda MK, O'Shea KM, Tintinu A, Xu W, Khairallah RJ, Barrows BR, Chess DJ, Azimzadeh AM, Harris WS, Sharov VG, Sabbah HN, Stanley WC. Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc Res. 2009;81: 319-327.
13. Metcalf RG, James MJ, Gibson RA, Edwards JR, Stubberfield J, Stuklis R, Roberts-Thomson K, Young GD, Cleland LG. Effects of fish-oil supplementation on myocardial fatty acids in humans. Am J Clin Nutr. 2007;85:1222-1228.
14. McMillin JB, Bick RJ, Benedict CR. Influence of dietary fish oil on mitochondrial function and response to ischemia. Am J Physiol. 1992; 263:H1479-H1485.
15. Pepe S, Tsuchiya N, Lakatta EG, Hansford RG. PUFA and aging modulate cardiac mitochondrial membrane lipid composition and Ca2+ activation of PDH. Am J Physiol. 1999;276:H149-H158.
16. Chicco AJ, Sparagna GC. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Physiol Cell Physiol. 2007;292:C33-C44.
17. Schlame M, Ren M, Xu Y, Greenberg ML, Haller I. Molecular symmetry in mitochondrial cardiolipins. Chem Phys Lipids. 2005;138:38-49.
18. Sparagna GC, Chicco AJ, Murphy RC, Bristow MR, Johnson CA, Rees ML, Maxey ML, McCune SA, Moore RL. Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure. J Lipid Res. 2007; 48:1559-1570.
19. Sparagna GC, Johnson CA, McCune SA, Moore RL, Murphy RC. Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry. J Lipid Res. 2005;46:1196-1204.
20. Chess DJ, Lei B, Hoit BD, Azimzadeh AM, Stanley WC. Effects of a high saturated fat diet on cardiac hypertrophy and dysfunction in response to pressure overload. J Card Fail. 2008;14:82-88.
21. Khairallah RJ, Khairallah M, Gelinas R, Bouchard B, Young ME, Allen BG, Lopaschuk GD, Deschepper CF, Des Rosiers C. Cyclic GMP signaling in cardiomyocytes modulates fatty acid trafficking and prevents triglyceride accumulation. J Mol Cell Cardiol. 2008;45:230-239.
22. Ruiz J, Antequera T, Andres AI, Petron M, Muriel E. Improvement of a solid phase extraction method for analysis of lipid fractions in muscle foods. Analytica Chimica Acta. 2004;520:201-205.
23. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 1986;27:114-120.
24. Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, Porter CB, Borkon AM. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation. 2004;110:1645-1649.
25. Tsuchimochi H, Sugi M, Kuro-o M, Ueda S, Takaku F, Furuta S, Shirai T, Yazaki Y. Isozymic changes in myosin of human atrial myocardium induced by overload. Immunohistochemical study using monoclonal antibodies. J Clin Invest. 1984;74:662-665.
26. Okere IC, Young ME, McElfresh TA, Chess DJ, Sharov VG, Sabbah HN, Hoit BD, Ernsberger P, Chandler MP, Stanley WC. Low carbohydrate/ high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension. Hypertension. 2006;48:1116-1123.
27. Hauff KD, Hatch GM. Cardiolipin metabolism and Barth Syndrome. Prog Lipid Res. 2006;45:91-101.
28. Vreken P, Valianpour F, Nijtmans LG, Grivell LA, Plecko B, Wanders RJ, Barth PG. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys Res Commun. 2000;279: 378-382.
29. Heerdt PM, Schlame M, Jehle R, Barbone A, Burkhoff D, Blanck TJJ. Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device. Ann Thorac Surg. 2002;73:1216-1221.